Christopher B Capel

Practice Areas

Extensive experience advising emerging and established companies, both privately and publicly held, in corporate, securities, and technology law matters. Practice emphasizes mergers, acquisitions and divestitures; intellectual property licensing, collaborations and transfers; strategic alliances/collaborations/joint-ventures; private equity/venture capital financings; other funding/financing/investment transactions; securities offerings; public company compliance; corporate governance; international transactions. Includes focus on pharmaceutical, biotech, medical device and other life sciences and agtech transactions.

Career

Since 1990: Smith Anderson. 1986-90: White & Case, LLP, New York NY. 1985-86: Judicial Law Clerk to Sam J. Ervin, III, U.S. Appeals Court, Fourth Circuit. 1979-82: Wachovia Bank, Commercial Banker.

Professional Memberships

North Carolina Bar (1985); New York Bar (1987). Board of Directors, North Carolina Biosciences Organization (NCBio). Member of American, NC, and NY Bar Associations. Past Chair, Business Law Section of NC Bar Association. Listed: Chambers USA, Corporate/M&A (2006-2022); The Best Lawyers in America ("Lawyer of the Year" Raleigh/Research Triangle market: 2020 in Securities Regulation; 2019/2017/2014 in Securities/Capital Markets; 2010 in Mergers & Acquisitions); also listed in Biotechnology Law, Corporate Law, M&A, Securities/Capital Markets, Securities Regulation, Venture Capital; IFLR1000: M&A.

Personal

JD (honors) and Law Review, University of North Carolina School of Law, 1985

BA Economics, University of North Carolina at Chapel Hill, 1979.